Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Mangoceuticals Q2 EPS $(0.57) Up From $(1.35) YoY, Sales $168.109K Up From $163.163K YoY

Author: Benzinga Newsdesk | August 14, 2025 03:54pm
Mangoceuticals (NASDAQ:MGRX) reported quarterly losses of $(0.57) per share. This is a 57.78 percent increase over losses of $(1.35) per share from the same period last year. The company reported $168.109 thousand in sales this quarter. This is a 3.03 percent increase over sales of $163.163 thousand the same period last year.

Posted In: MGRX


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist